Hot Pursuit     04-Jul-24
Zydus Lifesciences Ltd spurts 2.26%, rises for third straight session
Zydus Lifesciences Ltd is quoting at Rs 1119.95, up 2.26% on the day as on 12:49 IST on the NSE. The stock is up 91.44% in last one year as compared to a 25.55% gain in NIFTY and a 46.49% gain in the Nifty Pharma index.

Zydus Lifesciences Ltd rose for a third straight session today. The stock is quoting at Rs 1119.95, up 2.26% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.28% on the day, quoting at 24354.6. The Sensex is at 80227.97, up 0.3%. Zydus Lifesciences Ltd has added around 6.8% in last one month.

Meanwhile, Nifty Pharma index of which Zydus Lifesciences Ltd is a constituent, has added around 4.63% in last one month and is currently quoting at 19915.3, up 1.3% on the day. The volume in the stock stood at 13.33 lakh shares today, compared to the daily average of 15.07 lakh shares in last one month.

The benchmark July futures contract for the stock is quoting at Rs 1125.9, up 2.2% on the day. Zydus Lifesciences Ltd is up 91.44% in last one year as compared to a 25.55% gain in NIFTY and a 46.49% gain in the Nifty Pharma index.

The PE of the stock is 31.94 based on TTM earnings ending March 24.

Previous News
  Zydus Life rises on USFDA nod for heart failure drug
 ( Hot Pursuit - 10-Jul-24   15:36 )
  Zydus receives USFDA approval for Zituvimet™ XR tablets
 ( Corporate News - 19-Jul-24   13:58 )
  Zydus receives USFDA tentative approval for Letermovir tablets
 ( Corporate News - 23-Mar-24   14:00 )
  Zydus Lifesciences Ltd soars 0.37%, rises for fifth straight session
 ( Hot Pursuit - 14-Feb-24   13:00 )
  Zydus Lifesciences receives USFDA tentative approval for Diroximel Fumarate Delayed-Release Capsules
 ( Corporate News - 10-Jul-24   16:03 )
  Zydus enters into exclusive licensing and supply agreement with Viwit
 ( Corporate News - 13-Sep-24   21:09 )
  Zydus' transdermal patch manufacturing facility completes USFDA inspection
 ( Corporate News - 01-Oct-24   12:26 )
  Zydus Life’s Ahmedabad facility gets EIR from USFDA
 ( Hot Pursuit - 01-Oct-24   12:13 )
  Zydus Lifesciences fixes record date for buyback of shares
 ( Market Beat - Reports 09-Feb-24   17:03 )
  Zydus Lifesciences Ltd soars 0.09%, rises for fifth straight session
 ( Hot Pursuit - 30-Jun-23   13:00 )
  Zydus Lifesciences gets approval from CDSCO for phase 2 clinical trial of ZYIL1 in ALS patients
 ( Hot Pursuit - 25-Oct-23   10:55 )
Other Stories
  Avantel Q2 PAT jumps 42% YoY to Rs 23 cr
  05-Oct-24   17:03
  Equitas SFB total deposits jump 29% YoY in Q2 FY25
  05-Oct-24   16:28
  Ujjivan SFB total deposits rises 17% in Q2 FY25
  05-Oct-24   15:34
  L&T Finance retail disbursements jump 12% YoY in Q2 FY25
  05-Oct-24   14:31
  Bandhan Bank records over 21% YoY jump in loan book during Q2 FY25; deposits at Rs 1.42 lakh crore
  05-Oct-24   13:32
  Lupin's Pune-based biotech facility gets 5 observations from US FDA
  05-Oct-24   13:20
  Macrotech Developers pre-sales jumps 21% YoY in Q2 FY25
  05-Oct-24   09:04
  UCO Bank’s total advances jump 19% YoY in Q2 FY25
  04-Oct-24   15:15
  Vakrangee Ltd leads losers in 'A' group
  04-Oct-24   15:00
  Kamdhenu Ventures Ltd leads losers in 'B' group
  04-Oct-24   14:45
Back Top